HEART-SAU: Interest of the HEART Score for the Management of Patients With Chest Pain in Emergency Department

Sponsor
Université de Reims Champagne-Ardenne (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05675267
Collaborator
(none)
50
7.7

Study Details

Study Description

Brief Summary

Chest pain is a frequent reason of consultation in emergency department. Emergency physician have to identify patients at high risk of Acute Coronary Syndrome from those presenting a lower risk.

Condition or Disease Intervention/Treatment Phase
  • Other: data collection

Detailed Description

The aim of the study is to study the interest of the HEART score for the management of patients with chest pain in emergency department

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Interest of the HEART Score for the Management of Patients With Chest Pain in Emergency Department
Anticipated Study Start Date :
Jan 10, 2023
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
patient with chest pain

Other: data collection
HEART score calculation

Outcome Measures

Primary Outcome Measures

  1. HEART score [Day 0]

    Cardiovascular risk evaluated using HEART score. HEART score includes 5 items on history of chest pain, electrocardiogram, patient's age, cardiovascular risk factors and initial troponin. Each item is coded from 0 to 2 points, the overall score ranges from 0 to 10 points. Score between 0 and 3 indicated low risk of major adverse cardiovascular event, Score between 4 and 6 indicated moderate risk of major adverse cardiovascular event, Score between 7 and 10 indicated high risk of major adverse cardiovascular event

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:

men and women Aged more than 18 Chest pain Consulting in emergency department Agreeing to participate to the study

Exclusion Criteria:

aged less than 18 not agreeing to participate to the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Université de Reims Champagne-Ardenne

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Université de Reims Champagne-Ardenne
ClinicalTrials.gov Identifier:
NCT05675267
Other Study ID Numbers:
  • 2022_RIPH_019_HEART-SAU
First Posted:
Jan 9, 2023
Last Update Posted:
Jan 9, 2023
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Université de Reims Champagne-Ardenne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 9, 2023